← Open Payments lookup

KYOUNG BAEK: Open Payments

NPI 1982159174 · ENGLEWOOD CLIFFS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$619 in 17 payments from 9 companies in 2025. Trend: 2023 $89 · 2024 $694 · 2025 $619

Food & beverage: $619
CompanyPaymentsAmount
Madrigal Pharmaceuticals3$256
GlaxoSmithKline, LLC.2$139
Janssen Biotech, Inc.4$82
GENZYME CORPORATION3$57
Takeda Pharmaceuticals U.S.A., Inc.1$20
Phathom Pharmaceuticals, Inc.1$19
Aimmune Therapeutics, Inc.1$18
ABBVIE INC.1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: REZDIFFRA, NUCALA, TREMFYA, DUPIXENT, TRELEGY ELLIPTA, ENTYVIO, VOQUEZNA, ZENPEP.

Industry payments across NJ — which companies pay providers there.